Cediranib
Drug timelines are a Plus or Pro feature.
55 regulatory and trial events tracked for Cediranib, covering 2009-01-19 to 2026-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can... [Phase 1, Phase 2]